Fmoc-D-His(Mtt)-OH is an Fmoc-protected, D-configured histidine derivative in which the imidazole side chain bears an Mtt (4-methyltrityl) protecting group. The molecule contains an Fmoc carbamate on the α-amino functionality, a free carboxylic acid at the α-position, and a protected histidine imidazole that is masked to reduce side reactions during peptide coupling. In peptide chemistry, this protected amino acid is employed as a building block for stepwise assembly of histidine-containing peptides under conditions that require orthogonal side-chain protection and controlled chemoselectivity.
CAT No: CP25558
CAS No:200926-19-8
Synonyms/Alias:Fmoc-D-His(Mtt)-OH;200926-19-8;AmbotzFAA1075;FMOC-D-HIS-OH;Fmoc-D-His(tau-Mtt)-OH;CTK8E7398;ZINC71788128;RT-012941
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-im-p-methyltrityl-D-histidine
Fmoc-D-His(Mtt)-OH is a D-configured histidine derivative bearing an Fmoc-protected alpha-amino group and an Mtt-protected side-chain imidazole, where the Mtt group masks the nucleophilic N atoms of the histidine ring. The molecule contains a chiral center at the amino acid backbone, a carboxylic acid suitable for C-terminal activation, and orthogonal protection that separates backbone coupling from side-chain deprotection chemistry. The imidazole ring, once unmasked, can participate in acid-base catalysis and metal coordination, while the Fmoc group enables standard base-labile removal during stepwise peptide assembly. The combination of stereodefined D-histidine architecture and orthogonally protected side-chain functionality makes the compound a practical chiral intermediate for peptide building block preparation and downstream amino acid derivatization.
1. Peptide Synthesis
Fmoc-D-His(Mtt)-OH supports solid-phase peptide synthesis workflows by providing an Fmoc-protected amino acid whose carboxylic acid can be activated for peptide bond formation while the D-stereocenter is preserved. The Mtt-protected imidazole prevents premature side-chain participation during coupling and allows controlled unmasking at a later stage to generate a free histidine side chain for subsequent transformations. Orthogonal protection enables sequential steps where backbone deprotection and side-chain availability can be timed to match coupling and modification needs. D-histidine incorporation can be applied to peptide analog construction, epitope mapping scaffolds, and stereochemically defined peptide libraries where histidine positioning and chirality influence structure and reactivity.
2. Chemical Biology
Fmoc-D-His(Mtt)-OH can be employed in chemical biology research requiring histidine-like coordination sites and pH-responsive nucleophilicity within peptide or small-molecule conjugates. The protected imidazole allows stable handling during synthesis, while deprotection yields an imidazole that can bind metal ions or participate in proton-coupled interactions relevant to biomolecular recognition studies. Fmoc chemistry facilitates incorporation into peptide probes and labeling handles that maintain side-chain integrity during assembly. Resulting D-histidine-containing constructs can be utilized for molecular recognition probes, enzyme-binding studies, and mechanistic investigations where stereochemistry and imidazole availability govern binding modes and local electrostatics.
3. Bioconjugation Chemistry
Fmoc-D-His(Mtt)-OH serves as a protected histidine building block for preparing conjugation-ready peptides and linkers that incorporate a masked imidazole for controlled downstream functionalization. The Mtt group provides a chemoselective strategy to keep the imidazole from reacting with electrophiles or metal-mediated coupling reagents during earlier synthetic steps, while later deprotection can expose the side-chain for conjugation or coordination-based attachment. The Fmoc-protected amino group supports stepwise assembly of bioconjugate precursors with defined sequence context and spacing. D-histidine-containing conjugates can then be used to generate biomolecule-modifying reagents, affinity tags, or coordination-stabilized linkers for analytical and materials-facing applications.
4. Side-Chain Functionalization
Fmoc-D-His(Mtt)-OH enables side-chain functionalization strategies that depend on orthogonal protection of the histidine imidazole. The Mtt-protected imidazole can be selectively removed to reveal a free histidine ring, which can then undergo targeted transformations such as metal-coordination templating, nucleophilic derivatization, or incorporation into peptidomimetic motifs with defined donor-acceptor properties. The carboxylic acid and Fmoc-protected amine support further peptide coupling or conversion into activated intermediates for fragment assembly. Stereodefined D-histidine functionality supports the construction of chiral analogs for structure-activity relationship studies and synthetic methodology development focused on imidazole-mediated reactivity control.
5. Process Chemistry Intermediate
Fmoc-D-His(Mtt)-OH is suitable for process chemistry intermediate preparation where orthogonally protected amino acid derivatives are required for scalable peptide building block manufacturing. The Fmoc group provides a robust, base-labile protection handle for repeated coupling cycles, while the Mtt-protected imidazole supports chemoselective side-chain unmasking without exposing the imidazole during early stages. The D-configuration provides stereochemical fidelity that can be critical for reproducible product profiles in peptide analog production and for consistent downstream deprotection outcomes. The compound can be integrated into industrial fine chemical synthesis routes that rely on protected amino acid chemistry to generate defined chiral intermediates for peptide science, biochemical research reagents, and specialty manufacturing of amino acid-based materials.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.